Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zectivimod by LG Chem for Ulcerative Colitis: Likelihood of Approval
Zectivimod is under clinical development by LG Chem and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase...
Zectivimod by LG Chem for Ulcerative Colitis: Likelihood of Approval
Zectivimod is under clinical development by LG Chem and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase...
LR-20062 by LG Chem for Haemophilus influenzae Type B Infections: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Haemophilus influenzae Type B Infections. According...
LR-20062 by LG Chem for Diphtheria: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Diphtheria. According to GlobalData, Phase I...
LR-20062 by LG Chem for Tetanus: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Tetanus. According to GlobalData, Phase I...
LR-20062 by LG Chem for Poliomyelitis: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Poliomyelitis. According to GlobalData, Phase I...
LR-20062 by LG Chem for Hepatitis B: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Hepatitis B. According to GlobalData, Phase...
LR-20062 by LG Chem for Pertussis (Whooping Cough): Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Pertussis (Whooping Cough). According to GlobalData,...
LR-19155 by LG Chem for Non-Small Cell Lung Cancer: Likelihood of Approval
LR-19155 is under clinical development by LG Chem and currently in Phase I for Non-Small Cell Lung Cancer. According to...
LR-19155 by LG Chem for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
LR-19155 is under clinical development by LG Chem and currently in Phase I for Transitional Cell Carcinoma (Urothelial Cell Carcinoma)....
LR-20062 by LG Chem for Meningitis: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase II for Meningitis. According to GlobalData, Phase II...
LR-19155 by LG Chem for Renal Cell Carcinoma: Likelihood of Approval
LR-19155 is under clinical development by LG Chem and currently in Phase I for Renal Cell Carcinoma. According to GlobalData,...
Zectivimod by LG Chem for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
Zectivimod is under clinical development by LG Chem and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...
LR-19155 by LG Chem for Metastatic Melanoma: Likelihood of Approval
LR-19155 is under clinical development by LG Chem and currently in Phase I for Metastatic Melanoma. According to GlobalData, Phase...
LR-19018 by LG Chem for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
LR-19018 is under clinical development by LG Chem and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...
LR-19123 by LG Chem for Type 2 Diabetes: Likelihood of Approval
LR-19123 is under clinical development by LG Chem and currently in Phase I for Type 2 Diabetes. According to GlobalData,...